Beyond Air

Garden City, United States

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

$5.0M raised

Jan 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Beyond Air raised?

Beyond Air has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are Beyond Air's investors?

Beyond Air's investors include Avenue Capital Group, Streeterville Capital.

Where is Beyond Air headquartered?

Beyond Air is headquartered in Garden City, United States.

What does Beyond Air do?

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

What stage is Beyond Air at?

Beyond Air is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 14, 2026.

MLA

"Beyond Air — Funding & Investors." VCBacked, January 14, 2026, https://www.vcbacked.co/company/beyond-air. Accessed July 2, 2026.

APA

VCBacked. (2026). Beyond Air — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/beyond-air

Wikipedia (cite web)

{{cite web |title=Beyond Air — Funding & Investors |url=https://www.vcbacked.co/company/beyond-air |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 14, 2026.